Multiple physiological and pathological roles associated with osteolytic disease are ascribed to ANGPTL4 including promotion of osteoclast-mediated bone resorption, cartilage degradation, angiogenesis and vascular permeability, as well as tumour cell growth and metastasis. This evidence concerns the gene ANGPTL4 and neoplasm.